{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 0.0, "regularMarketPrice": 12.0, "trailingAnnualDividendRate": 78.0, "trailingPE": 18.461538, "trailingAnnualDividendYield": 6.5, "epsTrailingTwelveMonths": 0.65, "sharesOutstanding": 3288640000, "bookValue": 436.7195, "fiftyDayAverage": 11.60744, "fiftyDayAverageChange": 0.39256, "fiftyDayAverageChangePercent": 0.03381969, "twoHundredDayAverage": 12.3209, "twoHundredDayAverageChange": -0.32089996, "twoHundredDayAverageChangePercent": -0.026045172, "marketCap": 39463682048, "priceToBook": 0.02747759, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1651212000000, "priceHint": 2, "marketState": "REGULAR", "exchange": "MUN", "shortName": "CHUGAI PHARMAC.UNSP.ADR 2", "longName": "Chugai Pharmaceutical Co., Ltd.", "messageBoardId": "finmb_685347", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683871561, "regularMarketDayHigh": 12.0, "regularMarketDayRange": "12.0 - 12.0", "regularMarketDayLow": 12.0, "regularMarketVolume": 41, "regularMarketPreviousClose": 12.0, "bid": 12.0, "ask": 12.4, "fullExchangeName": "Munich", "financialCurrency": "JPY", "regularMarketOpen": 12.0, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.6999998, "fiftyTwoWeekLowChangePercent": 0.061946884, "fiftyTwoWeekRange": "11.3 - 14.06", "fiftyTwoWeekHighChange": -2.0600004, "fiftyTwoWeekHighChangePercent": -0.14651497, "fiftyTwoWeekLow": 11.3, "fiftyTwoWeekHigh": 14.06, "symbol": "CUP0.MU"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2-1-1 Nihonbashi-Muromachi", "city": "Chuo", "zip": "103-8324", "country": "Japan", "phone": "81 3 3281 6611", "fax": "81 3 3281 6607", "website": "https://www.chugai-pharm.co.jp", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.", "fullTimeEmployees": 7771, "companyOfficers": [{"maxAge": 1, "name": "Dr. Osamu  Okuda", "age": 59, "title": "Pres, CEO & Representative Director", "yearBorn": 1963, "fiscalYear": 2021, "totalPay": {"raw": 1337590, "fmt": "1.34M", "longFmt": "1,337,590"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Toshiaki  Itagaki", "age": 62, "title": "Head of Fin. Supervisory Division, CFO, Exec. VP & Director", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Toshiya  Sasai", "title": "Exec. of Investor Relations Group & Corp. Communications Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Shinji  Hidaka", "title": "Exec. VP and Head of Marketing & Sales Division", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Junichi  Ebihara", "title": "Exec. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yoshiaki  Ohashi", "age": 62, "title": "SVP & Full-time Audit Supervisory Board Member", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tetsuya  Yamaguchi", "title": "Exec. VP and Head of Project, Lifecycle Management & Foundation Medicine Unit", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yoshiyuki  Yano", "title": "Exec. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Satoko  Shisai", "title": "Exec. VP & Head of Digital Transformation Unit", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Shigehiro  Yamada Ph.D.", "age": 58, "title": "Head of Sustainability Department & Full-Time Audit & Supervisory Board Member", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 1, "boardRisk": 6, "compensationRisk": 1, "shareHolderRightsRisk": 9, "overallRisk": 5, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}